Qiagen N.V.

  • WKN: 901626
  • ISIN: NL0000240000
  • Land: Netherland

Nachricht vom 02.05.2012 | 14:02

DGAP-DD: QIAGEN N.V. english



Notification concerning transactions by persons performing managerial
responsibilities pursuant to section 15a of the WpHG

Directors' Dealings notification transmitted by DGAP - a company of
EquityStory AG.
The person with duty of notification is solely responsible for the content
of this announcement.
---------------------------------------------------------------------------

Details of the person subject to the disclosure requirement
Last name: Colpan
First name: Metin

Position: Member of an administrative or supervisory body

Information about the transaction with duty of notification

Description of the financial instrument: Common Shares
ISIN/WKN of the financial instrument: NL0000240000
Type of transaction: Sale of Common Shares
Date: 26.04.2012
Price: 16.31
Currency: USD
No. of items: 1440
Total amount traded: 23486
Place: New York

Explanation for publication:

Sale of 1,440 Common Shares to reimburse the tax liability subsequent to
the RSU Release of 2,694 Common Shares on 04/25/2012 according to a Rule
10b5-1 Sales Plan.

Information about the company with duty of publication

Issuer: QIAGEN N.V.
Spoorstraat 50
5911 KJ Venlo
Niederlande
ISIN: NL0000240000
WKN: 901626


End of Directors' Dealings Notification 
(c) DGAP 02.05.2012

DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

ID 15146

Anleihe im Fokus

7,75% p.a. - Rendite aus Familienhand

– Zeichnungsstart: 23. Mai – Börse Frankfurt
– Zeichnung ab 1.000 Euro
– Laufzeit 5 Jahre
– WKN: A1TNA7
– 100% Rückzahlungskurs

GBC-Fokusbox

Syzygy AG: Aktie kaufen

Die nach den ersten drei Monaten des laufenden Jahres von Syzygy präsentierten Zahlen liegen im Rahmen unserer Erwartungen. Angesichts unserer unveränderten Prognosen behalten wir das bisherige Kursziel von 5 € bei und erneuern das Rating KAUFEN.

Aktuelle Research-Studie

Orad Hi-Tec Systems Ltd

Original-Research: Orad Hi Tec Systems (von VEM Aktienbank AG): Kaufen

21. Mai 2013